Pricing Log in Create free account

Dyne Therapeutics, Inc. (DYN) vs Telix Pharmaceuticals Limited (TLX)

Dyne Therapeutics, Inc. and Telix Pharmaceuticals Limited are both Biotechnology companies. Dyne Therapeutics, Inc. and Telix Pharmaceuticals Limited are of similar size ($3.2B and $3.2B). Across the 8 metrics below, Dyne Therapeutics, Inc. leads on 4 and Telix Pharmaceuticals Limited on 4.

Valuation

Metric DYN TLX Biotechnology median
P/E n/m — 10.26
P/S n/m — 9.18
P/B 4.13 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales n/m n/m 8.98
Earnings yield (19.00%) — (34.89%)
Free cash flow yield (16.56%) 0.00% (24.52%)

Profitability

Metric DYN TLX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (81.57%) 0.00% (50.12%)
Return on assets (60.29%) 0.00% (45.60%)
Return on invested capital (1,956.27%) 0.00% 0.00%

Growth

Metric DYN TLX Biotechnology median
Revenue growth (TTM) — — 6.26%
EPS growth (last fiscal year) (2.97%) (120.00%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DYN TLX Biotechnology median
Debt to equity 0.30 1.18 0.00
Current ratio 12.02 2.01 4.89
Net debt to EBITDA 2.05 6.25 1.01

Dividend

Metric DYN TLX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DYN TLX Biotechnology median
Market cap 3.24b 3.21b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack